- Home
- SSSS vs INFU Comparison
SSSS vs INFU Comparison
Compare SSSS & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- INFU
- Stock Information
- Founded
- SSSS 2010
- INFU 2005
- Country
- SSSS United States
- INFU United States
- Employees
- SSSS N/A
- INFU N/A
- Industry
- SSSS Finance: Consumer Services
- INFU Medical/Dental Instruments
- Sector
- SSSS Finance
- INFU Health Care
- Exchange
- SSSS Nasdaq
- INFU Nasdaq
- Market Cap
- SSSS 118.1M
- INFU 136.2M
- IPO Year
- SSSS N/A
- INFU N/A
- Fundamental
- Price
- SSSS $4.87
- INFU $9.11
- Analyst Decision
- SSSS Buy
- INFU
- Analyst Count
- SSSS 2
- INFU 0
- Target Price
- SSSS $6.00
- INFU N/A
- AVG Volume (30 Days)
- SSSS 164.2K
- INFU 78.6K
- Earning Date
- SSSS 11-07-2024
- INFU 11-07-2024
- Dividend Yield
- SSSS N/A
- INFU N/A
- EPS Growth
- SSSS N/A
- INFU 60.96
- EPS
- SSSS N/A
- INFU 0.07
- Revenue
- SSSS $5,903,895.00
- INFU $132,783,999.00
- Revenue This Year
- SSSS N/A
- INFU $10.49
- Revenue Next Year
- SSSS $6.05
- INFU $8.84
- P/E Ratio
- SSSS N/A
- INFU $129.89
- Revenue Growth
- SSSS 5.43
- INFU 8.17
- 52 Week Low
- SSSS $3.32
- INFU $5.74
- 52 Week High
- SSSS $5.44
- INFU $10.99
- Technical
- Relative Strength Index (RSI)
- SSSS 52.13
- INFU 70.90
- Support Level
- SSSS $4.70
- INFU $8.75
- Resistance Level
- SSSS $5.44
- INFU $9.97
- Average True Range (ATR)
- SSSS 0.27
- INFU 0.47
- MACD
- SSSS -0.02
- INFU 0.29
- Stochastic Oscillator
- SSSS 29.99
- INFU 73.85
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.